secwatch.observer — SEC 8-K summary
======================================

Issuer:     REPLIGEN CORP (RGEN)
CIK:        0000730272
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0001193125-24-040727
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Repligen Q4 revenue down 16.6% to $155.7M; net loss $0.46/share
---------------------------------------------------------------

- Q4 2023 revenue $155.7M vs $186.8M in Q4 2022; full year $638.8M vs $801.5M.
- GAAP net loss $25.5M ($0.46 per diluted share) vs profit of $48.7M ($0.85) in Q4 2022.
- Adjusted EPS $0.33 vs $0.68; book-to-bill ratio 1.03 for second straight quarter.
- FY2024 guidance: revenue $620M-$650M, adjusted EPS $1.42-$1.49.
- Closed Metenova acquisition; launched TangenX SC; issued $600M convertible notes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730272/000119312524040727/0001193125-24-040727-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730272/000119312524040727/d742672d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-040727

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer